Invention Application
- Patent Title: LECTIN-LIKE OXIDIZED LDL RECEPTOR 1 ANTIBODIES AND METHODS OF USE
-
Application No.: US15390067Application Date: 2016-12-23
-
Publication No.: US20170260272A1Publication Date: 2017-09-14
- Inventor: Kurt Alex HELDWEIN , Jennifer BROGDON , William DOLE , John TRAUGER , Yuting TANG , Julia NEUGEBAUER , Annika SCHMID
- Applicant: Kurt Alex HELDWEIN , Jennifer BROGDON , William DOLE , John TRAUGER , Yuting TANG , Julia NEUGEBAUER , Annika SCHMID
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Main IPC: C07K16/28
- IPC: C07K16/28
Abstract:
The present invention relates to monoclonal antibodies binding to human lectin-like oxidized LDL (low density lipoprotein) receptor 1 (hereinafter, sometimes referred to as “LOX-1”), and pharmaceutical compositions and methods of treatment comprising the same.
Public/Granted literature
- US09988455B2 Methods of treating cardiovascular disorders with lectin-like oxidized LDL receptor 1 antibodies Public/Granted day:2018-06-05
Information query
